Arvinas Inc (ARVN)
31.60
-0.94
(-2.89%)
USD |
NASDAQ |
Apr 25, 16:00
31.60
0.00 (0.00%)
After-Hours: 20:00
Arvinas Shareholders Equity (Quarterly): 660.00M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 660.00M |
| September 30, 2023 | 457.20M |
| June 30, 2023 | 463.60M |
| March 31, 2023 | 511.00M |
| December 31, 2022 | 564.90M |
| September 30, 2022 | 621.50M |
| June 30, 2022 | 670.60M |
| March 31, 2022 | 723.30M |
| December 31, 2021 | 781.70M |
| September 30, 2021 | 817.74M |
| June 30, 2021 | 582.95M |
| March 31, 2021 | 615.30M |
| Date | Value |
|---|---|
| December 31, 2020 | 642.20M |
| September 30, 2020 | 205.12M |
| June 30, 2020 | 197.78M |
| March 31, 2020 | 211.71M |
| December 31, 2019 | 226.69M |
| September 30, 2019 | 134.16M |
| June 30, 2019 | 116.51M |
| March 31, 2019 | 127.74M |
| December 31, 2018 | 136.67M |
| September 30, 2018 | 36.32M |
| June 30, 2018 | 44.28M |
| December 31, 2017 | 0.2459M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
116.51M
Minimum
Jun 2019
817.74M
Maximum
Sep 2021
484.42M
Average
564.90M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 89.01B |
| Bristol-Myers Squibb Co | 29.43B |
| Janux Therapeutics Inc | 344.35M |
| Geron Corp | 247.95M |
| Verastem Inc | 57.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.305B |
| Total Liabilities (Quarterly) | 644.60M |
| Debt to Equity Ratio | 0.0012 |
| Current Ratio | 4.979 |
| Net Debt Paydown Yield | 0.00% |